Krispy Kreme soars 40% on deal with McDonald's to sell its doughnuts nationwide
By Tomi Kilgore
Deal will double 'points of access' for Krispy Kreme, starting later this year
Shares of Krispy Kreme Inc. rocketed higher Tuesday, after the doughnut seller announced an expanded partnership with McDonald's Corp., in which its doughnuts will start becoming available at the fast-food giant's restaurants across the U.S.
The rollout of the partnership will begin in the second half of 2024, with Krispy Kreme doughnuts expected to be available nationwide by the end of 2026.
Krispy Kreme's stock (DNUT) soared 39.4% to $17.35, their highest point in more than two years, smashing the previous record one-day gain of 14.1% seen on Aug. 19, 2021.
McDonald's shares (MCD) were unchanged.
"The top request we receive from consumers, every day, is, 'please bring Krispy Kreme to my town,'" said Krispy Kreme Chief Executive Josh Charlesworth. "Partnering with McDonald's on a national scale will provide our fans and doughnut lovers unprecedented daily access to fresh doughnuts and the joy that is Krispy Kreme."
The company said the partnership is expected to more than double "points of access" for customers. It has been scaling its supply chain as it readies for the expansion.
As of the end of 2023, Krispy Kreme said it had 7,372 points of access in the U.S., while McDonald's had more than 13,449 restaurants in the U.S.
The rally in Krispy Kreme's stock has turned it positive for this year, as it has now gained nearly 15% in 2024, while McDonald's shares have shed about 5% and the S&P 500 index SPX has gained 9%.
-Tomi Kilgore
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
03-26-24 1658ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth